|
| 36504562 | Diversity's Pandemic Distractions. | Health Matrix Clevel | 2022 |
| 37309445 | The Legal Weaponization of Racialized DNA: A New Genetic Politics of Affirmative Action. | Georget J Law Mod Crit Race Perspect | 2021 |
| 28829262 | Science Is Complex-So Is Race. | Am J Bioeth | 2017 |
| 29254462 | Pills for Prejudice: Implicit Bias and Technical Fix for Racism. | Am J Law Med | 2017 |
| 25789805 | 'When are you from?' Time, space, and capital in the molecular reinscription of race. | Br J Sociol | 2015 |
| 23289691 | The troubling persistence of race in pharmacogenomics. | J Law Med Ethics | 2012 |
| 21552237 | Mandating race: how the USPTO is forcing race into biotech patents. | Nat Biotechnol | 2011 |
| 21857129 | The two (institutional) cultures: a consideration of structural barriers to interdisciplinarity. | Perspect Biol Med | 2011 |
| 19348695 | Race and ancestry in biomedical research: exploring the challenges. | Genome Med | 2009 |
| 18840235 | Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients. | J Law Med Ethics | 2008 |
| 19593457 | Race, Genes, and Justice: A Call to Reform the Presentation of Forensic DNA Evidence in Criminal Trials. | Brooklyn Law Rev | 2008 |
| 19227819 | Exploiting race in drug development: BiDil's interim model of pharmacogenomics. | Soc Stud Sci | 2008 |
| 17679713 | BiDil for heart failure in black patients. | Ann Intern Med | 2007 |
| 17894171 | Race in a bottle. Drugmakers are eager to develop medicines targeted at ethnic groups, but so far they have made poor choices based on unsound science. | Sci Am | 2007 |
| 17947567 | Genetics. The science and business of genetic ancestry testing. | Science | 2007 |
| 16912052 | Being specific about race-specific medicine. | Health Aff (Millwood) | 2006 |
| 16997802 | Race, pharmacogenomics, and marketing: putting BiDil in context. | Am J Bioeth | 2006 |
| 17093476 | Patenting race. | Nat Biotechnol | 2006 |
| 17018831 | Genes, race, and population: avoiding a collision of categories. | Am J Public Health | 2006 |
| 15799501 | "Ethnic drugs". | Hastings Cent Rep | 2005 |
| 17333581 | From disparity to difference: how race-specific medicines may undermine policies to address inequalities in health care. | South Calif Interdiscip Law J | 2005 |
| 16459407 | BiDil: false promises: faulty statistics and reasoning have lead to the first "racial medicine". | Genewatch | 2005 |
| 16219647 | BiDil: race medicine or race marketing? | Health Aff (Millwood) | 2005 |
| 15976430 | Pharmacogenetics and ethnically targeted therapies: racial drugs need to be put in context. | BMJ | 2005 |
| 15990879 | Misreading race and genomics after BiDil. | Nat Genet | 2005 |
| 15052858 | How a drug becomes "ethnic": law, commerce, and the production of racial categories in medicine. | Yale J Health Policy Law Ethics | 2004 |
| 14593217 | Getting the numbers right: statistical mischief and racial profiling in heart failure research. | Perspect Biol Med | 2003 |
| 15212025 | What's the use? Law and authority in patenting human genetic material. | Stanford Law Pol Rev | 2003 |
| 12171097 | Biotechnology and the legal constitution of the self: managing identity in science, the market, and society. | Hastings Law J | 2000 |